Autism Research Institute
Autism Research Review International
1987 to 2006, Volumes 1 to 20
a b c d e f g h i j k l m n o p q r s t u v w x y z
L
L-carnitine, 1996, Vol. 10(3) pp. 4; 1999, Vol. 13(2) pp. 4; 2005, Vol. 19(2) pp. 6.
L-carnosine, 2003, Vol. 17(1) pp. 1; 2005, Vol. 19(2) pp. 6; 2005, Vol. 19(3) pp. 7.
L-dopa therapy, 1998, Vol. 12(1) pp. 4
L-5HTP, 1987, Vol. 01(4) pp. 7. See also 5-HTP
La Campagne, John, 1988, Vol. 02(1) pp. 5; 1994, Vol. 08(4) pp. 5.
La Vigna, Gary
laboratory tests. See diagnosis
lactase, 2001, Vol. 15(4) pp. 2; 2006, Vol. 20(1) pp. 4.
lactate, 1999, Vol. 13(4) pp. 4
lactic acidosis, 1987, Vol. 01(3) pp. 4; 1990, Vol. 04(1) pp. 2.
Lactobacillus GG, 2001, Vol. 15(3) pp. 4
Lagae, Lieven G., 1998, Vol. 12(2) pp. 2
LaGrow, 1988, Vol. 02(3) pp. 2–3
Laidler, Jim, 2001, Vol. 15(2) pp. 1; 2001, Vol. 15(3) pp. 1.
Laikind, Paul, 1987, Vol. 01(2) pp. 1; 2001, Vol. 15(1) pp. 7.
Lainhart, Janet E., 2003, Vol. 17(3) pp. 2
Laird, Charles, 1991, Vol. 05(2) pp. 2
Lambert, B.L., 2005, Vol. 19(1) pp. 6
Lamberti, J. Steven, 2005, Vol. 19(3) pp. 4
Laminack, Lyndon, 1990, Vol. 04(2) pp. 2
lamotrigine, 1993, Vol. 07(4) pp. 5; 1998, Vol. 12(2) pp. 5.
Lancet, The
Landa, Rebecca, 1993, Vol. 07(1) pp. 5; 1993, Vol. 07(2) pp. 6.
Landalf, Helen, 1998, Vol. 12(2) pp. 3; 1998, Vol. 12(3) pp. 5; 1999, Vol. 13(1) pp. 4.
Landau-Kleffner syndrome
as autoimmune disorder, 1999, Vol. 13(2) pp. 4; 2001, Vol. 15(1) pp. 7.
causes, 1991, Vol. 05(1) pp. 2
corticosteroids for, 1991, Vol. 05(2) pp. 1; 1995, Vol. 09(2) pp. 1; 1995, Vol. 09(3) pp. 1.
diagnosis, 1991, Vol. 05(1) pp. 2; 1991, Vol. 05(2) pp. 6; 1994, Vol. 08(2) pp. 6; 1995, Vol. 09(2) pp. 2; 1995, Vol. 09(3) pp. 6; 1995, Vol. 09(4) pp. 3; 1997, Vol. 11(3) pp. 4.
and hearing difficulties, 1991, Vol. 05(1) pp. 2
information package (ARI), 1995, Vol. 09(1) pp. 6; 1995, Vol. 09(4) pp. 3.
intravenous gamma globulin treatment for, 1997, Vol. 11(1) pp. 1
subtypes, 1991, Vol. 05(4) pp. 6
surgery for, 1991, Vol. 05(1) pp. 1; 1991, Vol. 05(4) pp. 6; 1992, Vol. 06(1) pp. 6; 1995, Vol. 09(2) pp. 2; 1996, Vol. 10(2) pp. 1; 2002, Vol. 16(2) pp. 7.
landfills, 2002, Vol. 16(1) pp. 4
Landry, Reginald, 2006, Vol. 20(2) pp. 3
Lang, B., 2001, Vol. 15(1) pp. 7
Langdell, 1989, Vol. 03(4) pp. 5
Langee, Harvey, 1990, Vol. 04(2) pp. 2
Langseth, Lillian, 1995, Vol. 09(4) pp. 5
language disorders. See also communication problems, speech problems
ABA (Applied Behavior Analysis) for, 2002, Vol. 16(1) pp. 2
acquisition of language and prognosis, 1988, Vol. 02(1) pp. 3
auditory integration training for, 1999, Vol. 13(2) pp. 2
B6 for, 1990, Vol. 04(4) pp. 7; 1995, Vol. 09(2) pp. 7.
babytalk for, 1989, Vol. 03(2) pp. 5
and behavior, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
brain abnormalities and, 1987, Vol. 01(1) pp. 4; 2002, Vol. 16(4) pp. 4.
in catatonia, 2000, Vol. 14(4) pp. 4
computers and software for, 1988, Vol. 02(1) pp. 3; 1988, Vol. 02(4) pp. 2; 1997, Vol. 11(4) pp. 1; 1999, Vol. 13(3) pp. 6; 2000, Vol. 14(4) pp. 5.
conversation skills, 1999, Vol. 13(2) pp. 5; 2002, Vol. 16(3) pp. 6.
DAN! Protocol for, 1997, Vol. 11(1) pp. 6
developmental language disorder, 1987, Vol. 01(4) pp. 6; 2004, Vol. 18(2) pp. 4.
devices for, 1988, Vol. 02(1) pp. 3
Dialyzable Leukocyte Extract for, 1989, Vol. 03(4) pp. 2
diet for, 2002, Vol. 16(3) pp. 1
DMG for (See DMG)
dolphins for, 1989, Vol. 03(4) pp. 2
drugs (anticoagulants) for, 1997, Vol. 11(1) pp. 1; 1997, Vol. 11(2) pp. 7.
drugs (anticonvulsants) for, 1994, Vol. 08(2) pp. 7
drugs (antidepressants) for, 1996, Vol. 10(4) pp. 7; 1998, Vol. 12(4) pp. 1; 2000, Vol. 14(2) pp. 4.
drugs (antipsychotics) for, 1990, Vol. 04(1) pp. 1
drugs (fenfluramine) for, 1987, Vol. 01(3) pp. 2
drugs (lithium) for, 1988, Vol. 02(1) pp. 1; 1989, Vol. 03(3) pp. 4.
drugs (naltrexone) for, 1989, Vol. 03(3) pp. 1–2
early intervention for, 1991, Vol. 05(4) pp. 5; 2003, Vol. 17(3) pp. 1.
echolalia treatment, 1987, Vol. 01(3) pp. 5
from Epstein-Barr infection, 2001, Vol. 15(1) pp. 4
expressive and understanding compared, 1990, Vol. 04(4) pp. 2
facilitated communication for, 1990, Vol. 04(4) pp. 1; 1991, Vol. 05(2) pp. 6; 1991, Vol. 05(4) pp. 3; 1993, Vol. 07(3) pp. 6.
genetic factors in, 1998, Vol. 12(4) pp. 4; 2001, Vol. 15(2) pp. 2; 2001, Vol. 15(3) pp. 2; 2003, Vol. 17(3) pp. 4.
immune dysfunction, 1999, Vol. 13(2) pp. 4; 2003, Vol. 17(1) pp. 6.
incidental language teaching for, 1987, Vol. 01(4) pp. 5
integrated and segregated schools compared, 1990, Vol. 04(2) pp. 5
L-carnosine for, 2003, Vol. 17(1) pp. 1
from low-frequency hearing loss, 2003, Vol. 17(3) pp. 4
magnesium for, 1990, Vol. 04(4) pp. 7; 1995, Vol. 09(2) pp. 7.
maternal antibodies and, 2003, Vol. 17(1) pp. 6
and mercury poisoning, 2000, Vol. 14(2) pp. 7; 2000, Vol. 14(3) pp. 1; 2003, Vol. 17(1) pp. 7.
music for, 1996, Vol. 10(1) pp. 5
naltrexone (low-dose) for, 2005, Vol. 19(2) pp. 2
Natural Language Paradigm (NLP) for, 1989, Vol. 03(2) pp. 5
and opiates, 1992, Vol. 06(1) pp. 1
PECS (Picture-Exchange Communication System) for, 1995, Vol. 09(3) pp. 5; 2002, Vol. 16(4) pp. 2.
PLAY Project for, 2003, Vol. 17(2) pp. 5
positive reinforcement plus visual screening, 1989, Vol. 03(4) pp. 6
prognosis and, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
routine interruption for, 1989, Vol. 03(3) pp. 5
and saccades, 2004, Vol. 18(3) pp. 4
in schizophrenia plus autism, 1989, Vol. 03(4) pp. 4
secretin for, 1999, Vol. 13(1) pp. 3; 2000, Vol. 14(2) pp. 3; 2000, Vol. 14(3) pp. 6.
serotonin and, 1987, Vol. 01(4) pp. 6
sign language for, 1987, Vol. 01(3) pp. 5
specific language impairment (SLI), 2000, Vol. 14(3) pp. 7; 2004, Vol. 18(4) pp. 6.
"talking head" for, 2001, Vol. 15(4) pp. 5
and thimerosol, 2003, Vol. 17(4) pp. 7
types of, 1987, Vol. 01(4) pp. 6; 1989, Vol. 03(1) pp. 2; 1990, Vol. 04(2) pp. 2; 2000, Vol. 14(3) pp. 7.
videos for conversation skills, 1990, Vol. 04(1) pp. 5
visual screening plus positive reinforcement, 1989, Vol. 03(4) pp. 6
vitamin B6 for, 1990, Vol. 04(4) pp. 7; 1995, Vol. 09(2) pp. 7.
vocabulary instruction, 2000, Vol. 14(4) pp. 5
vocalizing instruction techniques, 1989, Vol. 03(4) pp. 6
vowel-change distortion, 2003, Vol. 17(2) pp. 4
large neutral amino acids (LNAAs), 1996, Vol. 10(1) pp. 6
Larrington, Geraldene G., 1988, Vol. 02(2) pp. 6
Larson, Jan L., 1992, Vol. 06(3) pp. 5
Laski, Karen E., 1989, Vol. 03(2) pp. 5
LaStaiti, Elizabeth O'Neill (judge), 1995, Vol. 09(4) pp. 2
lateral nucleus, 2006, Vol. 20(4) pp. 5
Latitudes (newsletter), 1994, Vol. 08(2) pp. 6
Lau, Karen, 2005, Vol. 19(4) pp. 1
laughing, inappropriate, 2005, Vol. 19(4) pp. 5
L'Autism de L'Enfant (Le Lord and Sauvage), 1991, Vol. 05(2) pp. 7
LaVigna, Gary, 1988, Vol. 02(3) pp. 3; 1994, Vol. 08(1) pp. 1; 1994, Vol. 08(3) pp. 6.
Laviola, Giovanni, 2004, Vol. 18(1) pp. 6
Lawson, J.W., 1997, Vol. 11(3) pp. 6
lawsuits. See court/legal cases
LDN (low-dose naltrexone), 2005, Vol. 19(2) pp. 1–2. See also naltexone
Le, H., 2002, Vol. 16(3) pp. 5
Le Couteur, Ann, 1997, Vol. 11(2) pp. 4
Le Lord, Gilbert
and autism, 1988, Vol. 02(2) pp. 4; 1994, Vol. 08(1) pp. 5; 1995, Vol. 09(3) pp. 5; 1995, Vol. 09(4) pp. 7; 2003, Vol. 17(3) pp. 1; 2006, Vol. 20(4) pp. 1.
and celiac disease, 2004, Vol. 18(1) pp. 4
and fluoridation, 1998, Vol. 12(4) pp. 5
and porphyria, 2006, Vol. 20(3) pp. 7
and thiamine, 2002, Vol. 16(3) pp. 4
Leaf, Ronald, 1995, Vol. 09(3) pp. 5
leaky gut. See intestinal permeability
Learning Disabilities Association of America, 1993, Vol. 07(4) pp. 2; 2000, Vol. 14(3) pp. 1.
Lebedinskaya, K. S., 1988, Vol. 02(3) pp. 7
LeBel, C. P., 1992, Vol. 06(2) pp. 7
Leber's blindness, 1990, Vol. 04(1) pp. 4
Leboyer, Marion, 1992, Vol. 06(2) pp. 2
Leckman, James, 1996, Vol. 10(3) pp. 2
left-handedness, 1987, Vol. 01(4) pp. 2; 1988, Vol. 02(1) pp. 1. See also handedness
legal/court cases. See court/legal cases
LeGendre, Nancy, 1999, Vol. 13(1) pp. 3
legislation
AB 18 1988, Vol. 02(2) pp. 1
AB 135 1990, Vol. 04(2) pp. 1
Access to Medical Treatment Act, 1997, Vol. 11(3) pp. 3
Chaffee bill, 1990, Vol. 04(3) pp. 3
Health Freedom Act of 19 1990, Vol. 92(S) pp. ,; 1992, Vol. 06(3) pp. 2.
HR 416 1995, Vol. 09(2) pp. 6
HR 50 1995, Vol. 09(4) pp. 1
HR 170 1995, Vol. 09(p) pp. ,; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(3) pp. 7.
HR 574 1992, Vol. 06(3) pp. 2
HR 3642/S213 1991, Vol. 05(2) pp. 6
IDEA (Individuals with Disabilities Education Act), 1993, Vol. 07(4) pp. 2; 1995, Vol. 09(3) pp. 7; 1995, Vol. 09(4) pp. 1; 1998, Vol. 12(3) pp. 7.
National Childhood Vaccine Injury Act, 1990, Vol. 04(3) pp. 5; 1992, Vol. 06(3) pp. 6.
Pediatric Autism Research Act (SB 2263 and HR 4203), 1998, Vol. 12(3) pp. 6
SB 7 1998, Vol. 84(p) pp. ,; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(3) pp. 7.
SB S.3, 2004, Vol. 18(4) pp. 3
on SIBIS, 1996, Vol. 10(2) pp. 3
suspension of disabled students with firearms, 1995, Vol. 09(4) pp. 1
Vaccine Injury Compensation Program, 2003, Vol. 17(2) pp. 2
LeGrand appeal, 1990, Vol. 04(1) pp. 6
Leichtman, Lawrence, 1998, Vol. 12(4) pp. 3
LeJeune, Jerome, 1987, Vol. 01(4) pp. 2; 1995, Vol. 09(1) pp. 2; 1997, Vol. 11(4) pp. 3.
LeLord, Gilbert
B6/magnesium research, 1987, Vol. 01(4) pp. 3; 1992, Vol. 06(4) pp. 4; 1995, Vol. 09(2) pp. 7; 1995, Vol. 09(4) pp. 3; 1997, Vol. 11(4) pp. 3; 2000, Vol. 14(3) pp. 3.
brainflow decrease in autistics, 1992, Vol. 06(4) pp. 4
vitamin B6 and magnesium's synergy, 2003, Vol. 17(2) pp. 7
Lemke, Leslie, 1989, Vol. 03(1) pp. 1
Lennox, Carolyn, 1988, Vol. 02(4) pp. 5
Lennox-Gastaut syndrome, 1994, Vol. 08(2) pp. 7
Lensing, Patrick, 1992, Vol. 06(1) pp. 2
Leo, John, 1994, Vol. 08(4) pp. 2
Leo, Raphael J., 1997, Vol. 11(1) pp. 4
Leominster (MA)
Leon, Loretta, 1987, Vol. 01(3) pp. 7
Leonard, Virginia, 1991, Vol. 05(4) pp. 7
leptin, 2004, Vol. 18(2) pp. 2
Lerman, Pinchas, 1991, Vol. 05(2) pp. 1–2, 6
Lerman-Sagie, Tally, 1991, Vol. 05(1) pp. 2; 1991, Vol. 05(2) pp. 1.
Lerner, Vladimir, 1999, Vol. 13(3) pp. 2
Lesch-Nyhan disorder, 1988, Vol. 02(3) pp. 3; 1988, Vol. 02(4) pp. 5.
Leslie, Alan M., 1987, Vol. 01(4) pp. 1; 1990, Vol. 04(2) pp. 2.
"Lessons from secretin" (Volkmar), 1999, Vol. 13(4) pp. 7
Let Me Hear Your Voice (Maurice), 1994, Vol. 08(1) pp. 3; 1994, Vol. 08(3) pp. 3; 1995, Vol. 09(1) pp. 5.
lethargy, 1998, Vol. 12(3) pp. 4; 2006, Vol. 20(4) pp. 2.
Lettick, Amy, 1994, Vol. 08(1) pp. 6
LEV. See Levetiracetam (Keppra)
levadopa therapy (L-dopa therapy), 1998, Vol. 12(1) pp. 4
Leventhal, Bennett, 1993, Vol. 07(4) pp. 4; 1999, Vol. 13(2) pp. 3.
levetiracetam (Keppra), 2002, Vol. 16(4) pp. 4
Levin, Alan, 1988, Vol. 02(2) pp. 3
Levin, Len, 1999, Vol. 13(2) pp. 5
Levine, Steve, 1992, Vol. 06(2) pp. 3
Levinson, Leslie, 1994, Vol. 08(1) pp. 5
Levy, Sidney, 1990, Vol. 04(3) pp. 1
Lewis, Cara, 2002, Vol. 16(1) pp. 7
Lewis, Carolyn, 2002, Vol. 16(1) pp. 7
Lewis, Lisa S., 1994, Vol. 08(3) pp. 7; 1995, Vol. 09(3) pp. 7; 2002, Vol. 16(1) pp. 3; 2002, Vol. 16(2) pp. 6; 2004, Vol. 18(3) pp. 3.
Lewis, Mark. H.
LH-RH loading tests, 1987, Vol. 01(4) pp. 7
Libutti, Andrea, 2006, Vol. 20(3) pp. 7
licensing of vaccines, 2000, Vol. 14(4) pp. 1
Lieberman, Laurence, 1993, Vol. 07(1) pp. 3
Liebzeit, K. A., 2002, Vol. 16(2) pp. 6
Lienemann, John, 1990, Vol. 04(1) pp. 1
life expectancy, 2002, Vol. 16(1) pp. 5. See also mortality
life skills. See also independent living, vocational training
bill paying, 1988, Vol. 02(1) pp. 5
color coding, 1990, Vol. 04(2) pp. 5
cooking, 1989, Vol. 03(3) pp. 5
dentist visits, 1989, Vol. 03(2) pp. 5
forward chaining training technique, 1990, Vol. 04(1) pp. 5
grocery shopping, 1987, Vol. 01(4) pp. 5
and inclusion, 1992, Vol. 06(4) pp. 1
purchasing, 1988, Vol. 02(2) pp. 6
videotapes on, 1987, Vol. 01(1) pp. 5
Lifter, Karin, 1994, Vol. 08(2) pp. 5
Lightdale, Jennifer R., 2000, Vol. 14(2) pp. 3; 2000, Vol. 14(3) pp. 6.
Lim, D.K., 2003, Vol. 17(1) pp. 6
limbic system abnormalities
and cerebellar damage, 1989, Vol. 03(2) pp. 4; 1990, Vol. 04(1) pp. 4; 1994, Vol. 08(2) pp. 7.
mirror neuron deficits, 2005, Vol. 19(4) pp. 2
prenatal insults to, 1994, Vol. 08(2) pp. 7
smallness in autistics' brains, 1987, Vol. 01(1) pp. 1; 1989, Vol. 03(1) pp. 4.
in Tourette's, 1990, Vol. 04(3) pp. 5
and utilization behavior, 1995, Vol. 09(3) pp. 4
in voles, 1992, Vol. 06(3) pp. 4
Lin, Melody, 1994, Vol. 08(1) pp. 6
Linday, Linda A., 1997, Vol. 11(3) pp. 4; 1999, Vol. 13(2) pp. 2; 2001, Vol. 15(2) pp. 6; 2002, Vol. 16(3) pp. 7.
Lindenmayer, J. P., 2000, Vol. 14(2) pp. 5
Linderman, T. M., 1999, Vol. 13(2) pp. 5
Lindscheid, Thomas, 1987, Vol. 01(3) pp. 1; 1990, Vol. 04(2) pp. 6; 1994, Vol. 08(2) pp. 4; 1996, Vol. 10(4) pp. 2.
Linter, C. M., 1988, Vol. 02(1) pp. 1–2
Lipkin, Ian, 2000, Vol. 14(2) pp. 4
lipoprotein, 2003, Vol. 17(1) pp. 5; 2005, Vol. 19(4) pp. 7.
lissencephaly, 2001, Vol. 15(2) pp. 2
lists. See resource guides
literacy. See education
lithium, 1988, Vol. 02(1) pp. 1; 1989, Vol. 03(3) pp. 4; 2002, Vol. 16(1) pp. 2; 2002, Vol. 16(3) pp. 4; 2003, Vol. 17(4) pp. 5; 2005, Vol. 19(3) pp. 2; 2006, Vol. 20(4) pp. 6.
Litt, Brian, 2001, Vol. 15(2) pp. 7
live vaccines, 2003, Vol. 17(2) pp. 1
liver abnormalities
detoxification in autistics, 1998, Vol. 12(3) pp. 2
from drugs, 1997, Vol. 11(3) pp. 2; 1998, Vol. 12(2) pp. 4; 2000, Vol. 14(1) pp. 2; 2000, Vol. 14(2) pp. 5; 2005, Vol. 19(3) pp. 4; 2005, Vol. 19(4) pp. 4.
glutaric acid analysis, 1998, Vol. 12(3) pp. 2
nicotinamide dinucleotide (NAD), 1999, Vol. 13(4) pp. 4
LKS. See Landau-Kleffner syndrome
Lloyd, John Wills, 1988, Vol. 02(3) pp. 8
LNH. See lymphoid nodular hyperplasia
loading tests, 1987, Vol. 01(4) pp. 7
Lockridge, Robin, 1993, Vol. 07(1) pp. 7
Lockwood, Kirk, 1995, Vol. 09(1) pp. 5
locus coeruleus, 1994, Vol. 08(4) pp. 4
"log rolling," 2004, Vol. 18(3) pp. 5
logical reasoning test, 1997, Vol. 11(1) pp. 7
Lohr, James B., 1996, Vol. 10(2) pp. 5
Lombroso, Paul J., 1995, Vol. 09(4) pp. 4; 1996, Vol. 10(2) pp. 2.
London, Eric, 2000, Vol. 14(4) pp. 3
London, Karen, 2000, Vol. 14(4) pp. 3
long QT syndrome, 2002, Vol. 16(1) pp. 5
Lonsdale, Derrick, 2002, Vol. 16(3) pp. 4
Lopez-Hurtado, Edith, 2005, Vol. 19(2) pp. 2
Lord, Catherine, 2001, Vol. 15(3) pp. 6; 2004, Vol. 18(3) pp. 5.
Lorimer, Peggy A., 2002, Vol. 16(2) pp. 6–7
Lost Children Fund, 1991, Vol. 05(4) pp. 4
Lott, Rex S., 1997, Vol. 11(2) pp. 6–7
Louisiana, 2000, Vol. 14(3) pp. 7
Lovaas, O. Ivar. See also early intervention
arguments about study, 1987, Vol. 01(1) pp. 3; 1987, Vol. 01(3) pp. 6.
behavior modification program, 1987, Vol. 01(1) pp. 2; 1995, Vol. 09(2) pp. 3; 2006, Vol. 20(3) pp. 1.
court cases, 1998, Vol. 12(2) pp. 6; 1998, Vol. 12(3) pp. 7.
early intervention, 1987, Vol. 01(1) pp. 2; 1992, Vol. 06(2) pp. 5; 1993, Vol. 07(1) pp. 1; 1994, Vol. 08(1) pp. 3; 1994, Vol. 08(3) pp. 3; 1995, Vol. 09(1) pp. 5; 1995, Vol. 09(3) pp. 7; 1995, Vol. 09(4) pp. 6; 1996, Vol. 10(1) pp. 2; 1998, Vol. 12(1) pp. 1; 1999, Vol. 13(4) pp. 1; 2000, Vol. 14(4) pp. 2; 2003, Vol. 17(3) pp. 1; 2005, Vol. 19(3) pp. 1.
as mentor, 2006, Vol. 20(3) pp. 3
operant conditioning, 1992, Vol. 06(3) pp. 3; 1994, Vol. 08(1) pp. 2.
rewards for autistics and non-autistics compared, 1993, Vol. 07(2) pp. 5
self-injury as manipulative ploy, 1993, Vol. 07(2) pp. 5
stereotypies, 1988, Vol. 02(2) pp. 2
Young Autism Project, 1999, Vol. 13(4) pp. 1
Lovaas method, 1998, Vol. 12(3) pp. 7. See also Lovaas, O. Ivar
Lovinger, Laurie, 1989, Vol. 03(3) pp. 5
Lown, Kenneth, 1997, Vol. 11(3) pp. 6
Loza, Molina, 1989, Vol. 03(4) pp. 2
LPS-induced proinflammatory cytokines, 2006, Vol. 20(4) pp. 6
Lucarelli, S., 1996, Vol. 10(3) pp. 4
Lucas (recovered autistic boy), 2004, Vol. 18(3) pp. 1
Lucyshyn, Joseph, 1994, Vol. 08(1) pp. 2
Luiselli, James K.
lupus, 2003, Vol. 17(3) pp. 5; 2004, Vol. 18(2) pp. 5.
Luscre, Deanna M., 1996, Vol. 10(4) pp. 5
Lutz, Beat, 2003, Vol. 17(4) pp. 4
Luvox. See fluvoxamine
Luzzatti, Luigi, 1997, Vol. 11(2) pp. 3
lyase (adenylosuccinate lyase), 1987, Vol. 01(2) pp. 1; 1996, Vol. 10(2) pp. 4; 2001, Vol. 15(1) pp. 7.
lyase test, 1987, Vol. 01(2) pp. 1
Lyme disease, 2000, Vol. 14(2) pp. 4
lymphocyte abnormalities, 1987, Vol. 01(2) pp. 2; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(2) pp. 4; 2002, Vol. 16(2) pp. 1; 2003, Vol. 17(4) pp. 4.
lymphocytic colitis, 2001, Vol. 15(1) pp. 1
lymphoid nodular hyperplasia, 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(2) pp. 1; 2005, Vol. 19(2) pp. 2; 2006, Vol. 20(2) pp. 1.